Neelam, A., and A. Kanaki. “Efficacy and Safety of Remogliflozin Etabonate in Type 2 Diabetes Mellitus Patients in a Tertiary Care Hospital”. International Journal of Basic & Clinical Pharmacology, vol. 10, no. 4, Mar. 2021, pp. 353-6, doi:10.18203/2319-2003.ijbcp20211014.